Skip to main content
. 2020 Jun 19;70(1):48–57. doi: 10.1007/s12020-020-02369-3

Table 2.

Metabolic measures

Variable Men without OSA (n = 15) Men with OSA (n = 15) p value
Fasting plasma glucose (mmol/l) 5.8 (0.3) 6.3 (0.4) p < 0.001
Fasting serum insulin (mU/l) 8.0 (4.9) 8.6 (3.8) 0.548
Glucose, OGTT AUC120 min (min × mmol/l) 938 (114) 1128 (119) p < 0.001
Insulin, OGTT AUC120 min (min × mU/l) 5241 (3340) 5404 (1893) 0.865
2-h plasma glucose (mmol/l) 7.0 (1.3) 8.8 (1.5) 0.001
Serum C-peptide (nmol/l) 0.7 (0.2) 0.9 (0.2) 0.039
HbA1c (mmol/mol, IFCC) 36.4 (2.4) 36.5 (2.7) 0.880
Fasting plasma triglycerides (mmol/l) 1.0 (0.4) 1.2 (0.4) 0.189
Fasting plasma HDL cholesterol (mmol/l) 1.3 (0.1) 1.3 (0.3) 0.901
Fasting plasma LDL cholesterol (mmol/l) 3.4 (0.9) 3.5 (0.7) 0.708
LDL/HDL 2.7 (0.8) 3.0 (1.0) 0.442
Fasting plasma NEFA (μM) 214 (77) 263 (87) 0.097
Fasting plasma glycerol (μM) 77 (29) 76 (23) 0.686
NEFA, OGTT AUC120 min (min × μmol/l) 11,413 (3694) 14,905 (4633) 0.021
Glycerol, OGTT AUC120 min (min × μmol/l) 6840 (2173) 7416 (2479) 0.475
Fasting plasma total GLP-1 (pmol/l) 17 (8.0) 18 (9.0) 0.864
GLP-1 total AUC120 min (min × pmol/l) 2564 (1221) 2935 (1318) 0.413

Data are shown as mean (SD). Blood samples were obtained during fasting or OGTT as indicated. The p values are from crude linear regression analyses with bootstrapped standard errors

HbA1c glycated hemoglobin (HbA1c), measured in whole blood, HDL high-density lipoprotein, LDL Low-density lipoprotein, NEFA nonesterified fatty acids, OGTT oral glucose tolerance test